# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001493152-25-013123
Filing Date
2025-09-12
Accepted
2025-09-12 06:07:02
Documents
23
Period of Report
2025-09-12
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | form8-k.htm iXBRL | 8-K | 60317
2 | EX-3.1 | ex3-1.htm | EX-3.1 | 2025
3 | EX-10.1 | ex10-1.htm | EX-10.1 | 121071
4 | EX-99.1 | ex99-1.htm | EX-99.1 | 27187
5 | EX-99.2 | ex99-2.htm | EX-99.2 | 31406
6 | EX-99.3 | ex99-3.htm | EX-99.3 | 97823
7 | GRAPHIC | form8-k_001.jpg | GRAPHIC | 221602
8 | GRAPHIC | ex3-1_001.jpg | GRAPHIC | 553543
9 | GRAPHIC | ex3-1_002.jpg | GRAPHIC | 897929
10 | GRAPHIC | ex10-1_001.jpg | GRAPHIC | 5093
11 | GRAPHIC | ex99-1_001.jpg | GRAPHIC | 3899
| Complete submission text file | 0001493152-25-013123.txt |  | 3160363

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
12 | XBRL SCHEMA FILE | bgms-20250912.xsd | EX-101.SCH | 3743
13 | XBRL DEFINITION FILE | bgms-20250912_def.xml | EX-101.DEF | 26581
14 | XBRL LABEL FILE | bgms-20250912_lab.xml | EX-101.LAB | 36613
15 | XBRL PRESENTATION FILE | bgms-20250912_pre.xml | EX-101.PRE | 25205
25 | EXTRACTED XBRL INSTANCE DOCUMENT | form8-k_htm.xml | XML | 5862

Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 251310002
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)